The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
American Society of Clinical Oncology Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males With Germ Cell Tumors
Abstract
Purpose: To provide recommendations on appropriate uses for serum markers of germ cell tumors (GCTs). Methods: Searches of MEDLINE and EMBASE identified relevant studies published in English. Primary outcomes included marker accuracy to predict the impact of decisions on outcomes. Secondary outcomes included proportions of patients with elevated markers and statistical tests of elevations as prognostic factors. An expert panel developed consensus guidelines based on data from 82 reports. Results: No studies directly compared outcomes of decisions with versus without marker assays. The search identified few prospective studies and no randomized controlled trials; most were retrospective series. Lacking data on primary outcomes, most Panel recommendations are based on secondary outcomes (relapse rates and time to relapse). Recommendations: The Panel recommended against using markers to screen for GCTs, to decide whether orchiectomy is indicated, or to select treatment for patients with cancer of unknown primary. To stage patients with testicular nonseminomas, the Panel recommended measuring three markers (α-fetoprotein [AFP], human chorionic gonadotropin [hCG], and lactate dehydrogenase [LDH]) before and after orchiectomy and before chemotherapy for those with extragonadal nonseminomas. They also recommended measuring AFP and hCG shortly before retroperitoneal lymph node dissection and at the start of each chemotherapy cycle for nonseminoma, and periodically to monitor for relapse. The Panel recommended measuring postorchiectomy hCG and LDH for patients with seminoma and preorchiectomy elevations. They recommended against using markers to guide or monitor treatment for seminoma or to detect relapse in those treated for stage I. However, they recommended measuring hCG and AFP to monitor for relapse in patients treated for advanced seminoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,775
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709
American Joint Committee on Cancer (2002) · Springer eBooks · doi:10.1007/978-1-4757-3656-4 · Cited by 6,379
TNM Classification of Malignant Tumours
(2003) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471463752 · Cited by 3,946
SEER Cancer Statistics Review, 1975-2008, National Cancer Institute, Bethesda, MD
Howlader, N. (2011) · Medical Entomology and Zoology · Cited by 2,612
Harris, L., Fritsche, H., Mennel, R., Norton, L., Ravdin, P., Taube, S., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2364 · Cited by 2,217
Self-citation(1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.2.594 · Cited by 1,929
ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer
Locker, G. Y., Hamilton, S., Harris, J., Jessup, J. M., Kemeny, N., Macdonald, J. S., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2644 · Cited by 1,592
Self-citation(2010) · Handbook of Disease Burdens and Quality of Life Measures · doi:10.1007/978-0-387-78665-0_6514 · Cited by 1,385
(1975) · The Enzymes · doi:10.1016/s1874-6047(08)60212-7 · Cited by 1,247
Williams, S. D., Birch, R., Einhorn, L. H., Irwin, L., Greco, F. A., & Loehrer, P. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162302 · Cited by 1,170
Self-citationSturgeon, C. M., Duffy, M. J., Stenman, U.-H., Lilja, H., Brünner, N., Chan, D. W., Babaian, R., Bast, R. C., Dowell, B., Esteva, F. J., et al. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.105601 · Cited by 1,129
Self-citationMead, G. M., Stenning, S. P., Cook, P. A., Fosså, S. D., Horwich, A., Kaye, S. B., Oliver, R. T. D., deMulder, P., deWit, R., Stoter, G., et al. (1997) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 1,033
European Organization for Research and Treatment of Cancer
National Cancer Institute (2020) · Definitions · doi:10.32388/ykqg4k · Cited by 756
Krege, S., Beyer, J., Souchon, R., Albers, P., Albrecht, W., Algaba, F., Bamberg, M., Bodrogi, I., Bokemeyer, C., Cavallin-Ståhl, E., et al. (2008) · European Urology · doi:10.1016/j.eururo.2007.12.024 · Cited by 617
Bokemeyer, C., Nichols, C. R., Droz, J.-P., Schmoll, H.-J., Horwich, A., Gerl, A., Fossa, S. D., Beyer, J., Pont, J., Kanz, L., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.062 · Cited by 503
Self-citationMedical Treatment of Advanced Testicular Cancer
Feldman, D. R. (2008) · JAMA · doi:10.1001/jama.299.6.672 · Cited by 370
Einhorn, L. H., Williams, S. D., Loehrer, P. J., Birch, R., Drasga, R., Omura, G., & Greco, F. A. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.3.387 · Cited by 367
Self-citationMotzer, R. J., Nichols, C. J., Margolin, K. A., Bacik, J., Richardson, P. G., Vogelzang, N. J., Bajorin, D. F., Lara, P. N., Einhorn, L., Mazumdar, M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.4528 · Cited by 353
Self-citationNichols, C. R., Catalano, P. J., Crawford, E. D., Vogelzang, N. J., Einhorn, L. H., & Loehrer, P. J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1287 · Cited by 348
Self-citationJones, W. G., Fosså, S. D., Mead, G. M., Roberts, J. T., Sokal, M., Horwich, A., & Stenning, S. P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.003 · Cited by 307
Human chorionic gonadotropin in cancer
Stenman, U.-H., Alfthan, H., & Hotakainen, K. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.05.008 · Cited by 294
New discoveries on the biology and detection of human chorionic gonadotropin
Cole, L. A. (2009) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-7-8 · Cited by 286
McKenney, J. K., Heerema-McKenney, A., & Rouse, R. V. (2007) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e31803240e6 · Cited by 262
Human chorionic gonadotropin. I. Purification and physicochemical properties.
Bahl, O. P. (1969) · PubMed · Cited by 258
Steyerberg, E. W., Keizer, H. J., Fosså, S. D., Sleijfer, D. T., Toner, G. C., Schraffordt Koops, H., Mulders, P. F., Messemer, J. E., Ney, K., & Donohue, J. P. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.5.1177 · Cited by 254
Krege, S., Beyer, J., Souchon, R., Albers, P., Albrecht, W., Algaba, F., Bamberg, M., Bodrogi, I., Bokemeyer, C., Cavallin-Ståhl, E., et al. (2008) · European Urology · doi:10.1016/j.eururo.2007.12.025 · Cited by 252
Kurman, R. J., Scardino, P. T., McIntire, K. R., Waldmann, T. A., & Javadpour, N. (1977) · Cancer · doi:10.1002/1097-0142(197711)40:5<2136::aid-cncr2820400524>3.0.co;2-d · Cited by 248
Chan, R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.8978 · Cited by 230
(2008) · Cited by 225
Stephenson, A. J., Bosl, G. J., Motzer, R. J., Kattan, M. W., Stasi, J., Bajorin, D. F., & Sheinfeld, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.132 · Cited by 198
Self-citationFree human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms.
Marcillac, I., Troalen, F., Bidart, J., et al. (1992) · PubMed · Cited by 191
Hoskin, P., Dilly, S., Easton, D., Horwich, A., Hendry, W., & Peckham, M. J. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.7.1031 · Cited by 188
AFP-Producing Gastric Carcinoma: Multivariate Analysis of Prognostic Factors in 270 Patients
Adachi, Y., Tsuchihashi, J., Shiraishi, N., Yasuda, K., Etoh, T., & Kitano, S. (2003) · Oncology · doi:10.1159/000072332 · Cited by 180
Update on Late Relapse of Germ Cell Tumor: A Clinical and Molecular Analysis
George, D. W., Foster, R. S., Hromas, R. A., Robertson, K. A., Vance, G. H., Ulbright, T. M., Gobbett, T. A., Heiber, D. J., Heerema, N. A., Ramsey, H. C., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.019 · Cited by 166
Self-citationThe Value of Serum Tumor Markers in the Staging and Prognosis of Germ Cell Tumors of the Testis
Scardino, P. T., Cox, H. D., Waldmann, T. A., McIntire, K. R., Mittemeyer, B. T., & Javadpour, N. (1977) · The Journal of Urology · doi:10.1016/s0022-5347(17)58275-0 · Cited by 166
Late Relapses of Germ Cell Malignancies: Incidence, Management, and Prognosis
Oldenburg, J., Martin, J. M., & Fosså, S. D. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.1836 · Cited by 151
Gels, M. E., Hoekstra, H. J., Sleijfer, D. T., Marrink, J., de Bruijn, H. W., Molenaar, W. M., Freling, N. J. M., Droste, J. H. J., & Koops, H. S. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.5.1188 · Cited by 150
Fosså, S. D., Stenning, S. P., Gerl, A., Horwich, A., CLARK, P. I., Wilkinson, P. M., Jones, W. G., Williams, M. V., Oliver, R. T. D., Newlands, E. S., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690534 · Cited by 147
Lange, P. H., McIntire, K. R., Waldmann, T. A., Hakala, T. R., & Fraley, E. E. (1976) · New England Journal of Medicine · doi:10.1056/nejm197611252952207 · Cited by 139
LATE RELAPSE OF TESTICULAR GERM CELL NEOPLASMS: A DESCRIPTIVE ANALYSIS OF 122 CASES
Dieckmann, K., Albers, P., Claßen, J., de Wit, M., Pichlmeier, U., Rick, O., Müllerleile, U., & Kuczyk, M. A. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000154013.96349.36 · Cited by 126
SALVAGE SURGERY OF CHEMOREFRACTORY GERM CELL TUMORS WITH ELEVATED TUMOR MARKERS
Albers, P., GANZ, A., HANNIG, E., Miersch, W. D. E., & MÜLLER, S. C. (2000) · The Journal of Urology · doi:10.1016/s0022-5347(05)67365-x · Cited by 119
Javadpour, N., McIntire, K. R., & Waldmann, T. A. (1978) · Cancer · doi:10.1002/1097-0142(197812)42:6<2768::aid-cncr2820420636>3.0.co;2-z · Cited by 117
Late recurrences of germ cell malignancies: a population-based experience over three decades
Oldenburg, J., Alfsen, G. C., Wæhre, H., & Fosså, S. D. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603014 · Cited by 112
α-Fetoprotein in Nonneoplastic Hepatic Disorders
Bloomer, J. R. (1975) · JAMA · doi:10.1001/jama.1975.03260010040018 · Cited by 112
Discordance of human chorionic gonadotropin and alpha-fetoprotein in testicular teratocarcinomas
Braunstein, G. D., McIntire, K. R., & Waldmann, T. A. (1973) · Cancer · doi:10.1002/1097-0142(197305)31:5<1065::aid-cncr2820310505>3.0.co;2-h · Cited by 111
Hartmann, J. T., Einhorn, L. H., Nichols, C. R., Droz, J., Horwich, A., Gerl, A., Fosså, S. D., Beyer, J., Pont, J., Schmoll, H., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1641 · Cited by 103
Self-citationSteyerberg, E. W., Gerl, A., Fosså, S. D., Sleijfer, D. T., de Wit, R., Kirkels, W. J., Schmeller, N. T., Clemm, C., Habbema, J. D. F., & Keizer, H. J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.269 · Cited by 103
Perlin, E., Engeler, J. E., Edson, M., Karp, D., McIntire, K. R., & Waldmann, T. A. (1976) · Cancer · doi:10.1002/1097-0142(197601)37:1<215::aid-cncr2820370131>3.0.co;2-l · Cited by 95
Vergouwe, Y., Steyerberg, E. W., Foster, R. S., Sleijfer, D. T., Fosså, S. D., Gerl, A., de Wit, R., Roberts, J. T., & Habbema, J. D. F. (2006) · European Urology · doi:10.1016/j.eururo.2006.06.047 · Cited by 88
Tumor markers at the time of recurrence in patients with germ cell tumors
Trigo, J. M., Tabernero, J. M., Paz-Ares, L. G., Garc�a-Llano, J. L., Mora, J., LIANES, P., Esteban, E., Salazar, R., L�pez-L�pez, J. J., & Cort�s-Funes, H. (2000) · Cancer · Cited by 75
Serum Alpha-Fetoprotein and Human Chorionic Gonadotropin in Patients with Seminoma
Lange, P. H., Nochomovitz, L. E., Rosaí, J., Fraley, E. E., Kennedy, B. J., Bosl, G. J., Brisbane, J. U., Catàlona, W. J., Cochran, J. S., Comisarow, R. H., et al. (1980) · The Journal of Urology · doi:10.1016/s0022-5347(17)55500-7 · Cited by 75
Self-citationMarker Half-Life Analysis as a Prognostic Tool in Testicular Cancer
Lange, P. H., Vogelzang, N. J., Goldman, A. I., Kennedy, B. J., & Fraley, E. E. (1982) · The Journal of Urology · doi:10.1016/s0022-5347(17)53149-3 · Cited by 72
Vergouwe, Y., Steyerberg, E. W., Foster, R. S., Habbema, J. D. F., & Donohue, J. P. (2001) · The Journal of Urology · doi:10.1097/00005392-200101000-00021 · Cited by 57
Hereditary persistence of α-fetoprotein
Schefer, H., Mattmann, S., & Joss, R. (1998) · Annals of Oncology · doi:10.1023/a:1008243311122 · Cited by 56
Steyerberg, E. W., Keizer, H. J., Stoter, G., & Habbema, J. D. F. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90164-3 · Cited by 53
Steyerberg, E. W., Keizer, H. J., Sleijfer, D. T., Fosså, S. D., Bajorin, D. F., Gerl, A., de Wit, R., Kirkels, W. J., Koops, H. S., & Habbema, J. D. F. (2000) · Radiology · doi:10.1148/radiology.215.2.r00ma02437 · Cited by 39
A systematic review of lactate dehydrogenase isoenzyme 1 and germ cell tumors
von Eyben, F. E. (2001) · Clinical Biochemistry · doi:10.1016/s0009-9120(01)00236-3 · Cited by 38
HLA and Congenital Hypothyroidism
Cimino, P., Banks, R., Maclaren, N. K., Rosenbloom, E. K., Riley, W. J., Rosenbloom, A., & Root, A. (1980) · New England Journal of Medicine · doi:10.1056/nejm198011133032014 · Cited by 33
von Eyben, F. E., Skude, G., Fosså, S. D., Klepp, O., & Børmer, O. P. (1983) · Molecular and General Genetics MGG · doi:10.1007/bf00337825 · Cited by 31
van Dijk, M. R., Steyerberg, E. W., Stenning, S. P., & Habbema, J. D. F. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh350 · Cited by 22
Cited by
Henry, N. L., & Hayes, D. F. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.01.010 · Cited by 849
Self-citationTumor biomarkers for diagnosis, prognosis and targeted therapy
Zhou, Y., Tao, L., Qiu, J., Xu, J., Yang, X., Zhang, Y., Tian, X., Guan, X., Cen, X., & Zhao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01823-2 · Cited by 720
Cheng, L., Albers, P., Berney, D. M., Feldman, D. R., Daugaard, G., Gilligan, T., & Looijenga, L. H. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0029-0 · Cited by 462
Self-citationTesticular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Gilligan, T., Lin, D. W., Aggarwal, R., Chism, D., Cost, N., Derweesh, I. H., Emamekhoo, H., Feldman, D. R., Geynisman, D. M., Hancock, S. L., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0058 · Cited by 450
Self-citationSalani, R., Backes, F. J., Fung Kee Fung, M., Holschneider, C. H., Parker, L. P., Bristow, R. E., & Goff, B. A. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.03.008 · Cited by 428
Metadata
- Authors
- Gilligan, T. D., Seidenfeld, J., Basch, E. M., Einhorn, L. H., Fancher, T., Smith, D. C., Stephenson, A. J., Vaughn, D. J., Cosby, R., & Hayes, D. F.
- Venue
- Journal of Clinical Oncology
- Published
- 2010-07-10
- Volume
- 28
- Issue
- 20
- Pages
- 3388-3404
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2164233939
- Cited by
- 297
- References
- 62
- FWCI
- 15.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.